Obesity

Health

Weight-Loss Injections: Public Health Insurance Refuses Coverage — Parliament Divided

Ozempic and Wegovy are hailed as breakthroughs against obesity and heart disease, but millions of publicly insured individuals in Germany remain witho...

Redakcia 11. March 2026

Health

GLP-1 Drugs May Shield the Heart After a Heart Attack

A new study published in Nature Communications reveals that GLP-1 drugs like Ozempic and Wegovy can restore blood flow in the heart's tiny vessels aft...

Redakcia 10. March 2026

Health

How Fatty Liver Disease Works—and Why It's So Common

Once overlooked, metabolic dysfunction-associated steatotic liver disease (MASLD) now affects roughly one in three adults worldwide. Here's how fat si...

Redakcia 7. March 2026

Health

What Is Fatty Liver Disease and Why It's So Common

Fatty liver disease — now officially called MASLD — affects nearly 40% of the global population, yet most people don't know they have it. Here's how i...

Redakcia 7. March 2026

Health

GLP-1 Drugs Protect Hearts; Aspirin Fails Cancer Test

Two landmark findings are reshaping clinical medicine: GLP-1 drugs like Ozempic and Wegovy show powerful cardioprotection after heart attacks, while a...

Redakcia 6. March 2026

Health

How GLP-1 Drugs Work: The Science Behind Ozempic

GLP-1 receptor agonists like Ozempic and Wegovy have transformed obesity treatment. Here's how these drugs hijack the gut-brain axis to suppress appet...

Redakcia 5. March 2026

Health

Colon Cancer: Leading Cause of Death Under 50

New epidemiological data from 2026 confirms an alarming trend: colorectal cancer has become the leading cause of cancer deaths in adults under 50 in t...

Redakcia 5. March 2026

Health

Colorectal Cancer Now Top Killer for Adults Under 50

Colorectal cancer has overtaken all other cancers to become the leading cause of cancer death in adults under 50 in the United States, driven by risin...

Redakcia 5. March 2026